ReP USP - Resultado da busca

Filtros : "Mochly-Rosen" Limpar

Filtros

Artigo de periodico
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein-protein interaction inhibitor reveals a non-catalytic role for GAPDH oligomerization in cell death (2016)
Qvit, Nir; Joshi, Amit U.; Cunningham, Anna D.; Ferreira, Julio Cesar Batista ; Mochly-Rosen
Source: International Journal of Biological Chemistry. Unidade: ICB
Assunto: ANATOMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QVIT, Nir et al. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein-protein interaction inhibitor reveals a non-catalytic role for GAPDH oligomerization in cell death. International Journal of Biological Chemistry, v. 291, n. 26, p. 13608-13621, 2016Tradução . . Disponível em: https://doi.org/10.1074/jbc.M115.711630. Acesso em: 23 maio 2024.
APA
Qvit, N., Joshi, A. U., Cunningham, A. D., Ferreira, J. C. B., & Mochly-Rosen,. (2016). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein-protein interaction inhibitor reveals a non-catalytic role for GAPDH oligomerization in cell death. International Journal of Biological Chemistry, 291( 26), 13608-13621. doi:10.1074/jbc.M115.711630
NLM
Qvit N, Joshi AU, Cunningham AD, Ferreira JCB, Mochly-Rosen. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein-protein interaction inhibitor reveals a non-catalytic role for GAPDH oligomerization in cell death [Internet]. International Journal of Biological Chemistry. 2016 ; 291( 26): 13608-13621.[citado 2024 maio 23 ] Available from: https://doi.org/10.1074/jbc.M115.711630
Vancouver
Qvit N, Joshi AU, Cunningham AD, Ferreira JCB, Mochly-Rosen. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein-protein interaction inhibitor reveals a non-catalytic role for GAPDH oligomerization in cell death [Internet]. International Journal of Biological Chemistry. 2016 ; 291( 26): 13608-13621.[citado 2024 maio 23 ] Available from: https://doi.org/10.1074/jbc.M115.711630
Artigo de periodico
βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure (2011)
Ferreira, Julio Cesar Batista ; Brum, Patricia Chakur; Mochly-Rosen
Source: Journal of Molecular and Cellular Cardiology. Unidade: EEFE
Subjects: FISIOLOGIA, INSUFICIÊNCIA CARDÍACA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Julio Cesar Batista e BRUM, Patricia Chakur e MOCHLY-ROSEN,. βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology, v. 51, n. 4, p. 479-484, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.yjmcc.2010.10.020. Acesso em: 23 maio 2024.
APA
Ferreira, J. C. B., Brum, P. C., & Mochly-Rosen,. (2011). βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology, 51( 4), 479-484. doi:10.1016/j.yjmcc.2010.10.020
NLM
Ferreira JCB, Brum PC, Mochly-Rosen. βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51( 4): 479-484.[citado 2024 maio 23 ] Available from: https://doi.org/10.1016/j.yjmcc.2010.10.020
Vancouver
Ferreira JCB, Brum PC, Mochly-Rosen. βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51( 4): 479-484.[citado 2024 maio 23 ] Available from: https://doi.org/10.1016/j.yjmcc.2010.10.020

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024